ReposiTrak Net Worth
ReposiTrak Net Worth Breakdown | TRAK |
ReposiTrak Net Worth Analysis
ReposiTrak's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ReposiTrak's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ReposiTrak's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ReposiTrak's net worth analysis. One common approach is to calculate ReposiTrak's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ReposiTrak's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ReposiTrak's net worth. This approach calculates the present value of ReposiTrak's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ReposiTrak's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ReposiTrak's net worth. This involves comparing ReposiTrak's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ReposiTrak's net worth relative to its peers.
Enterprise Value |
|
To determine if ReposiTrak is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ReposiTrak's net worth research are outlined below:
| ReposiTrak generated a negative expected return over the last 90 days | |
| ReposiTrak is unlikely to experience financial distress in the next 2 years | |
| ReposiTrak currently holds 481.02 K in liabilities with Debt to Equity (D/E) ratio of 0.83, which is about average as compared to similar companies. ReposiTrak has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ReposiTrak's use of debt, we should always consider it together with its cash and equity. | |
| ReposiTrak has a strong financial position based on the latest SEC filings | |
| About 36.0% of ReposiTrak outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Randall K. Fields Sells 1,500 Shares of ReposiTrak Inc. Stock |
ReposiTrak Quarterly Good Will |
|
ReposiTrak uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ReposiTrak. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ReposiTrak's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
ReposiTrak Target Price Consensus
ReposiTrak target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ReposiTrak's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most ReposiTrak analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ReposiTrak stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ReposiTrak, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationReposiTrak Target Price Projection
ReposiTrak's current and average target prices are 18.12 and 29.00, respectively. The current price of ReposiTrak is the price at which ReposiTrak is currently trading. On the other hand, ReposiTrak's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On ReposiTrak Target Price
Know ReposiTrak's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ReposiTrak is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ReposiTrak backward and forwards among themselves. ReposiTrak's institutional investor refers to the entity that pools money to purchase ReposiTrak's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2025-03-31 | 111.3 K | Bank Of New York Mellon Corp | 2025-03-31 | 100.3 K | Northern Trust Corp | 2025-03-31 | 91.9 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 58.9 K | O'shaughnessy Asset Management Llc | 2025-03-31 | 45.3 K | Citadel Advisors Llc | 2025-03-31 | 39.3 K | Goss Wealth Management Llc | 2025-03-31 | 37.7 K | Goldman Sachs Group Inc | 2025-03-31 | 37.6 K | The Informed Momentum Company (formerly Eam Investors) | 2025-03-31 | 36.5 K | Handelsbanken Fonder Ab | 2025-03-31 | 1.5 M | Rice Hall James & Associates, Llc | 2025-03-31 | 853 K |
Follow ReposiTrak's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 335.92 M.Market Cap |
|
Project ReposiTrak's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.18 | 0.19 | |
| Return On Capital Employed | 0.10 | 0.10 | |
| Return On Assets | 0.10 | 0.11 | |
| Return On Equity | 0.11 | 0.12 |
When accessing ReposiTrak's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ReposiTrak's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ReposiTrak's profitability and make more informed investment decisions.
Evaluate ReposiTrak's management efficiency
ReposiTrak has return on total asset (ROA) of 0.0702 % which means that it generated a profit of $0.0702 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1417 %, meaning that it created $0.1417 on every $100 dollars invested by stockholders. ReposiTrak's management efficiency ratios could be used to measure how well ReposiTrak manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.19 this year. Return On Capital Employed is expected to rise to 0.10 this year. At this time, ReposiTrak's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 62.3 M this year, although the value of Non Current Liabilities Total will most likely fall to about 170.1 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.32 | 1.50 | |
| Tangible Book Value Per Share | 1.26 | 0.66 | |
| Enterprise Value Over EBITDA | 30.94 | 32.49 | |
| Price Book Value Ratio | 7.03 | 6.34 | |
| Enterprise Value Multiple | 30.94 | 32.49 | |
| Price Fair Value | 7.03 | 6.34 | |
| Enterprise Value | 80.8 M | 76.7 M |
Evaluating the management effectiveness of ReposiTrak allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The ReposiTrak Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 14.0243 | Revenue | Quarterly Revenue Growth 0.163 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ReposiTrak insiders, such as employees or executives, is commonly permitted as long as it does not rely on ReposiTrak's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ReposiTrak insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ReposiTrak Corporate Filings
F4 | 16th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 23rd of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 15th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 7th of May 2025 Other Reports | ViewVerify |
ReposiTrak Earnings Estimation Breakdown
The calculation of ReposiTrak's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ReposiTrak is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for ReposiTrak is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
ReposiTrak Earnings Projection Consensus
Suppose the current estimates of ReposiTrak's value are higher than the current market price of the ReposiTrak stock. In this case, investors may conclude that ReposiTrak is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ReposiTrak's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2026 | Current EPS (TTM) | |
| 1 | 82.6% | 0.0 | 0.0 | 0.34 |
ReposiTrak Earnings per Share Projection vs Actual
Actual Earning per Share of ReposiTrak refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ReposiTrak predict the company's earnings will be in the future. The higher the earnings per share of ReposiTrak, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ReposiTrak Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ReposiTrak, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ReposiTrak should always be considered in relation to other companies to make a more educated investment decision.ReposiTrak Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ReposiTrak's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-05-13 | 2025-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2025-02-12 | 2024-12-31 | 0.09 | 0.08 | -0.01 | 11 | ||
2024-11-14 | 2024-09-30 | 0.08 | 0.0763 | -0.0037 | 4 | ||
2024-09-30 | 2024-06-30 | 0.06 | 0.08 | 0.02 | 33 | ||
2024-05-15 | 2024-03-31 | 0.11 | 0.0747 | -0.0353 | 32 | ||
2024-02-14 | 2023-12-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2023-11-14 | 2023-09-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2023-09-28 | 2023-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2023-05-15 | 2023-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2023-02-14 | 2022-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2022-11-14 | 2022-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
2022-09-28 | 2022-06-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2022-05-16 | 2022-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2022-02-14 | 2021-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2021-11-15 | 2021-09-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2021-09-28 | 2021-06-30 | 0.06 | 0.04 | -0.02 | 33 | ||
2021-05-17 | 2021-03-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2021-02-16 | 2020-12-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2020-11-16 | 2020-09-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2020-09-28 | 2020-06-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2020-05-11 | 2020-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2020-02-10 | 2019-12-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2019-11-07 | 2019-09-30 | 0.03 | 0.0122 | -0.0178 | 59 | ||
2019-09-12 | 2019-06-30 | 0.05 | 0.0146 | -0.0354 | 70 | ||
2019-05-09 | 2019-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2019-02-07 | 2018-12-31 | 0.05 | 0.08 | 0.03 | 60 | ||
2018-11-08 | 2018-09-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2018-09-13 | 2018-06-30 | 0.04 | 0.06 | 0.02 | 50 | ||
2018-05-10 | 2018-03-31 | 0.06 | 0.02 | -0.04 | 66 | ||
2018-02-08 | 2017-12-31 | 0.04 | 0.06 | 0.02 | 50 | ||
2017-11-09 | 2017-09-30 | 0.04 | 0.01 | -0.03 | 75 | ||
2017-09-13 | 2017-06-30 | 0.05 | 0.03 | -0.02 | 40 | ||
2017-05-10 | 2017-03-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2016-02-08 | 2015-12-31 | -0.03 | 0.0055 | 0.0355 | 118 | ||
2015-11-09 | 2015-09-30 | -0.04 | -0.0319 | 0.0081 | 20 | ||
2015-09-14 | 2015-06-30 | -0.03 | -0.06 | -0.03 | 100 | ||
2015-05-07 | 2015-03-31 | -0.01 | -0.03 | -0.02 | 200 | ||
2015-02-05 | 2014-12-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2014-11-06 | 2014-09-30 | -0.04 | -0.02 | 0.02 | 50 | ||
2014-09-11 | 2014-06-30 | -0.02 | -0.03 | -0.01 | 50 | ||
2013-11-04 | 2013-09-30 | -0.04 | -0.0734 | -0.0334 | 83 | ||
2009-11-10 | 2009-09-30 | -0.03 | 0.0082 | 0.0382 | 127 | ||
2009-09-24 | 2009-06-30 | -0.04 | -0.02 | 0.02 | 50 | ||
2009-05-26 | 2009-03-31 | -0.07 | -0.21 | -0.14 | 200 | ||
2009-02-23 | 2008-12-31 | -0.11 | -0.12 | -0.01 | 9 | ||
2008-05-14 | 2008-03-31 | -0.13 | -0.03 | 0.1 | 76 | ||
2008-02-15 | 2007-12-31 | -0.09 | -0.16 | -0.07 | 77 | ||
2007-10-01 | 2007-09-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2007-09-30 | 2007-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2007-05-15 | 2007-03-31 | -0.06 | -0.1 | -0.04 | 66 |
ReposiTrak Corporate Management
| Joe Meherg | Senior Sales | Profile | |
| Derek Hannum | Chief Officer | Profile | |
| Edward Clissold | General Secretary | Profile | |
| John Merrill | Chief Officer | Profile | |
| Jozef Jamrich | Chief Officer | Profile | |
| Rob Fink | Investor Professional | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ReposiTrak. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy ReposiTrak Stock please use our How to buy in ReposiTrak Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReposiTrak. If investors know ReposiTrak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReposiTrak listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Dividend Share 0.069 | Earnings Share 0.34 | Revenue Per Share | Quarterly Revenue Growth 0.163 |
The market value of ReposiTrak is measured differently than its book value, which is the value of ReposiTrak that is recorded on the company's balance sheet. Investors also form their own opinion of ReposiTrak's value that differs from its market value or its book value, called intrinsic value, which is ReposiTrak's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReposiTrak's market value can be influenced by many factors that don't directly affect ReposiTrak's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReposiTrak's value and its price as these two are different measures arrived at by different means. Investors typically determine if ReposiTrak is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReposiTrak's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.